Table 6 Comparison of hazard ratios between Masaoka-Koga and proposed IASLC/ITMIG stages using Cox’s regression analysis
From: Evaluation of the new TNM-staging system for thymic malignancies: impact on indication and survival
Overall survival | Recurrence-free survival | |||||
|---|---|---|---|---|---|---|
HR | 95% CI | p value | HR | 95% CI | p value | |
Masaoka-Koga | ||||||
I + II | 1.00 | 0.054 | 1.00 | 0.03 | ||
III | 6.38 | 1.38–29.59 | 0.02 | 5.79 | 1.19–28.01 | 0.03 |
IVa + IVb | 3.64 | 0.75–17.67 | 0.11 | 8.1 | 1.78–36.79 | 0.007 |
IASLC/ITMIG | ||||||
I + II | 1.00 | 0.09 | 1.00 | 0.04 | ||
IIIa + IIIb | 5.71 | 1.19–27.49 | 0.03 | 3.66 | 0.91–14.67 | 0.07 |
IVa + IVb | 4.73 | 1.01–22.1 | 0.048 | 5.31 | 1.47–19.15 | 0.01 |